OTCM
LSDIF
Market cap0kUSD
Jun 10, Last price
0.00USD
Name
Lucy Scientific Discovery Inc
Chart & Performance
P/E
—
P/S
0.05
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
7k
Net income
-9m
L+45.48%
CFO
-4m
L+76.41%
Profile
Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North Cannabis, Inc. The company was incorporated in 2017 and is based in Victoria, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | |
| Income | ||||
Revenues | 7 | |||
Cost of revenue | 4 | |||
Unusual Expense (Income) | ||||
NOPBT | 3 | |||
NOPBT Margin | 36.15% | |||
Operating Taxes | 1,966 | 322 | ||
Tax Rate | 77,166.25% | |||
NOPAT | (1,964) | (322) | ||
Net income | (8,988) 45.48% | (6,178) -13.04% | ||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 7,500 | 88 | ||
BB yield | -5.13% | |||
| Debt | ||||
Debt current | 399 | 1,220 | ||
Long-term debt | 3,118 | 4,260 | ||
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | 1,843 | 5,427 | ||
| Cash flow | ||||
Cash from operating activities | (4,266) | (2,418) | ||
CAPEX | (300) | (34) | ||
Cash from investing activities | (266) | (34) | ||
Cash from financing activities | 6,192 | 2,250 | ||
FCF | (5,601) | 848 | ||
| Balance | ||||
Cash | 1,674 | 53 | ||
Long term investments | ||||
Excess cash | 1,674 | 53 | ||
Stockholders' equity | 4,679 | (4,778) | ||
Invested Capital | 4,794 | 4,820 | ||
ROIC | ||||
ROCE | 0.04% | |||
| EV | ||||
Common stock shares outstanding | 12,701 | 16,057 | ||
Price | 11.50 | |||
Market cap | 146,063 | |||
EV | 147,906 | |||
EBITDA | 104 | |||
EV/EBITDA | 1,421.98 | |||
Interest | 1,966 | 2,065 | ||
Interest/NOPBT | 77,164.17% | |||